Companies
Acquired by KnowBe4
Acquired by Apple
Acquired by Capital D
Acquired by Oracle
Acquired by Siemens
Acquired by ERT Inc
IPO: AREC
IPO: ORTX
IPO: FRLN
IPO: ACHL
IPO: MGTX
Acquired by Facebook
IPO: BKNG
Acquired by Anthropic
Explore our investments
-
Life Sciences investments
-
Assets under management£1.2bnCommitted to early-stage technology founders
-
Companies200+With over a 100 profitable exits
-
Combined ARR£653mAnnual recurring revenue across our companies
Companies
-
Achilles TherapeuticsBiopharmaceutical company developing precision T cell therapies
Life SciencesIPO -
Apollo TherapeuticsBiopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs Life SciencesGrowth
-
Axovia TherapeuticsGene therapy company developing disease-transformative medicines for ciliopathies Life SciencesExited
-
Bloomsbury GTXBiotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases Life SciencesExited
-
EpilepsyGTxBiotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy Life SciencesEarly Stage
-
EpsilogenImmuno-oncology company targeting cancer with the IgE class of antibodies Life SciencesEarly Stage
-
FreelineBiopharmaceutical company focused on the development of liver-directed gene therapies Life SciencesIPO
-
Meira GTXVertically integrated, clinical stage gene therapy company Life SciencesIPO
-
NovalGenImmuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer Life SciencesEarly Stage
-
Orchard TherapeuticsBiotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases Life SciencesIPO
-
Quell TherapeuticsA clinical stage company transforming lives in immune mediated disease Life SciencesGrowth
-
Senya TxTargeting LRG1 as a pathological regulator in a range of vascular diseases Life SciencesEarly Stage
